Jeremy Bender - Oct 16, 2023 Form 4 Insider Report for Fusion Pharmaceuticals Inc. (FUSN)

Role
Director
Signature
/s/Maria Stahl as Attorney-in-Fact for Jeremy Bender
Stock symbol
FUSN
Transactions as of
Oct 16, 2023
Transactions value $
$0
Form type
4
Date filed
10/16/2023, 04:58 PM
Previous filing
Aug 17, 2023
Next filing
Nov 17, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FUSN Stock Option (Right to Buy) Award $0 +34K $0.00 34K Oct 16, 2023 Common Stock 34K $4.16 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares subject to this option shall vest and become exercisable in 36 substantially equal monthly installments starting on November 16, 2023.